In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor®), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae-Reference-Cited by-同舟云学术

In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor®), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae

Published:1997-09 Issue:2 Volume:63 Page:157-160
ISSN:0034-5288
Container-title:Research in Veterinary Science
language:en
Short-container-title:Research in Veterinary Science

Author:

Hannan P.C.T,Windsor H.M,Ripley P.H

Publisher

Elsevier BV

Subject

General Veterinary

Reference17 articles.

1. The evaluation of tiamulin by injection for the treatment of enzootiic pneumonia and mycoplasmal arthritis of pigs;Burch,1984

2. Use of tiamulin in a herd of pigs seriously affected with Mycoplasma hyosynoviae arthritis;Burch;Veterinary Record,1984

3. Mycoplasma species identification based upon growth inhibition by specific antisera;Clyde;Journal of Immunology,1964

4. Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative;Drews;Antimicrobial Agents and Chemotherapy,1975

5. Resistance of Mycoplasma hyopneumoniae to chlortetracycline;Etheridge;Australian Veterinary Journal,1979

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 1,2,3-triazole-based pleuromutilin derivatives as potent gram-positive antibacterial agents;Bioorganic & Medicinal Chemistry Letters;2024-09

2. Recent advances in developing modified C14 side chain pleuromutilins as novel antibacterial agents;European Journal of Medicinal Chemistry;2024-04

3. Lameness in Pigs;Production Diseases in Farm Animals;2024

4. Preparation and Evaluation of Valnemulin Hydrochloride Taste-Masking Granules;Current Drug Delivery;2022-03

5. Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants;Frontiers in Veterinary Science;2022-02-11